SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016235
Filing Date
2023-10-04
Accepted
2023-10-04 16:14:13
Documents
13
Period of Report
2023-10-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20231004x8k.htm   iXBRL 8-K 38023
2 EX-99.1 mxct-20231004xex99d1.htm EX-99.1 30230
  Complete submission text file 0001558370-23-016235.txt   195751

Data Files

Seq Description Document Type Size
3 EX-101.SCH mxct-20231004.xsd EX-101.SCH 3130
4 EX-101.LAB mxct-20231004_lab.xml EX-101.LAB 15918
5 EX-101.PRE mxct-20231004_pre.xml EX-101.PRE 10320
7 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20231004x8k_htm.xml XML 4840
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 231308060
SIC: 8731 Services-Commercial Physical & Biological Research